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I. Introduction 
When a process involving enzyme-catalysis is studied, the measurement of 
the reaction-velocity under different conditions (such as enzyme and substrate 
concentration) and different physical variables (such as pH, temperature, ionic 
strength, etc.) yields a wealth of information. The interpretation of this infor-
mation - the study of enzyme kinetics - has substantially deepened our insight 
into the mechanism of action of enzymatic catalysis. 
The blood-clotting process consists of a very complicated sequence of enzyme 
actions. The conditions under which the blood-clotting enzymes operate differ in 
some essential points from the standard conditions, which are assumed to be 
fullfilled when "ordinary" enzyme kinetics apply. Some of the consequences 
of these differences will be discussed in this article. 
Although not too much is known about the reaction mechanism of the 
blood-clotting process, we do know enough to predict that an exact kinetic 
treatment of this process by means of relatively simple mathematics, as we aim 
to do here, is impossible without introducing gross simplifications. The logical 
consequence would be to drop the kinetic approach and stick to the well-known 
empirical relationships, such as the rectilinear relation that should exist between 
the logarithm of the concentration of the clotting-factor to be tested and the 
logarithm of the observed clotting-time. Such relations are of course important 
practical tools, but they have the disadvantage that they do not provide insight 
into the mechanism of the reaction studied. Possible implications of the linea-
rity on a log C - log t - plot will be discussed below. 
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In an attempt to apply enzyme kinetics to the clotting-process we have 
found that this process sometimes behaves as if it were a much simpler system 
than we knew it to be. This enabled us to obtain information about this seem-
ingly simple process, since we knew that it represents a function of the reaction-
sequence of blood-clotting. Thus there is a possibility that, although blood-
clotting as a whole is too complicated for a concise kinetic treatment, the study 
of simplified parts of the system will yield useful information. The bases of 
enzyme kinetics, as given sub II, V, and VI, are taken from ref. 1 and 2. The 
symbols and nomenclature are the same as those in ref. 4. As far as the nomen-
clature of the blood-clotting factors is involved, we follow the suggestions of the 
International Committee for the Nomenclature of blood-clotting factors (ref. 3). 
II. The Standard Model of Enzyme Kinetics 
Classical enzyme kinetics are based upon the assumption that enzyme-
molecules (E) in a solution containing an excess of substrate molecules (S) react 
reversely with these imbstrate molecules to form the enzymesubstrate com-
plex (C). This complex dissociates irreversibly into enzyme and product (P). 




Assuming (ex.) that the amount of substrate is much greater than the amount of 
enzyme we can put: 
(1) 
(2) 
in which Et is the total amount of enzyme and St the total amount of substrate 
added to the reaction medium 1 ). 
Further it is assumed ( ~) that the amount of C will be constant during a 
certain time after the reaction has been started. Then the production rate of C 
(v+ 1) will be equal to the disappearance rate, v_ 1 + V+z• 
(3) 
Finally (y) only initial rates are considered, i.e. the decline of reaction-velo-
city due to the decline of substrate concentration (because of its conversion to 
1) In the reaetion schemes E, C, and S denote molecules. In the mathematical formulas E, C, 
and S denote the concentration of those molecules. 
- I 
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product) is not taken into account. Under these conditions ((X, ~. y) the velocity 
of product formation (v) can be derived in the following way: 
V = V+2 = k+2 • C 
(3) --+ k+1·E·S=(k- 1 +k+2.)·C 
(1) & (2) & (3) --+ k+1 ·Et· St= C · (k- 1 + k+2 + k+1 · St) 
(4) & (6) 
or: 1 1 1 
k+2 · Et • ~ + k+2 · Et 
and as 
1 1 1 1 
- =Km. --- . --+---







The most convenient way to render this formula graphically, is to plot 
! against¾, which gives a straight line [the so-called Lineweaver-Burk plot; 
(ref. 5) (Fig. 1 )]. 
( E) 
K+1 1 
- k-1 + k2 = - K 
Fig. 1. The Lineweaver-Burk plot. The relationship between+ and¾ is shown for two different 
concentrations of enzyme (E and E'). 
(Note: k 1 = k+t• etc.; K = Km.) 
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Ill. A Model of the Clotting Process 
In accordance with Biggs and Macfarlane (ref. 6, 7) and Macfarlane, Owren 
and Ltischer (ref. 3) we will consider the clotting process as a series of protein 
interactions, in which each clotting-factor is in tum substrate to the action of the 
previous one, and the enzyme catalysing the conversion of the next one (Fig. 2). 
In formula: 
xn 
XI l •···· Contact 
Ix l •---xu. 
VII V1II l •---- XI. 
Contact····• l X l •···· IX:•++ 
~!·--• l •---- vm. Phospholipid Ca++ 
V 
x . . 
' : n 
; v.----•l I 
:. _____________ u----• 1 xm . . 
ca++ : 
1. ♦ Fibrin 





In this example E 1 can e.g. be activated F.XII; then S1 = F.XI, and 
E2 = P 1 = activated F. XI, etc. 
Already this is a gross simplification, as the role of dialysable factors 
(e.g.Ca++) is not taken into account and because all relations are supposed to be 
irreversible. Nor is the possibility considered that reactions occur of the type: 
E1 E2 
S1 -Pi--+ P2 (E) 
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Further enzyme inactivation mechanisms are ignored, as are inhibitions by 
excess of substrate or product. Still, this simple view already explains much of 
the peculiarities of the clotting process. 
One step of the reaction-sequence depicted above differs considerably from 
the standard model of enzyme kinetics. As both substrate and enzyme are 
proteins, the concentrations of which are probably of the same order of magni-
tude, the assumption that there is an excess of substrate is no longer valid. The 
consequences of sequential coupling of these reactions will be discussed later. 
IV. The Reaction-Velocity of the Clotting Process 
The velocity of the clotting process (v) is commonly deduced from the 
clotting-time (t). This is the time necessary for a critical concentration (C) of 
fibrin monomere to be formed. This critical concentration is the concentration 
of monomere necessary to obtain visible fibrin formation. Since the polymeri-
zation of fibrin monomere is a nonenzymatic process, the concentration of 
monomere necessary to obtain visible polymerization will be equal under equal 
physical conditions. This implies that the reaction-velocity of monomere for-
mation will be inversely proportional to the clotting-time. 
1 t 
t • v = C or----=~ (8) 
V C 
In this reasoning we have tacitly assumed that an instantaneous and clearly 
visible change in liquidity is observed when the fixed concentration C is 
de passed. 
In reality, this coagulation in the stricter sense requires a finite time to be 
completed, and this time in itself is dependent upon the coagulation-velocity. 
So, the moment at which coagulation is detected is only an arbitrarily chosen 
point in the process. To obtain reproducible results requires much training, or 
rigorous standardization of the criterion of fibrin formation as realised in the 
coagulometer (ref. 8, 9). 
V. Kinetics of One Step of the Clotting Process 
It must be assumed that in a reaction which is a part of the clotting process 
(except possibly the fibrinogen conversion) the concentrations of enzyme and 
substrate are of the same order of magnitude, since each substrate will turn into 
enzyme in the next stage of the process. It is, for instance, not very conceivable 
that factor XI will be present in a concentration much greater than the concen-
tration of factor XII and yet a concentration much smaller than that of fac-
tor IX. 
160 Hemker, Hemker, Loeliger 
When in the reaction-sequence: 
k+1 
E + S.:==:=C (A) 
k_1 
C ~ E + P (B) 
the supposition: 
S ► E is not valid; we must put: 
Et= E + C (1) 
St= S + C (9) 
(instead of: St R::i S) (2) 
This leads to equation 10, via a reasoning analogous to that sub II: 
v = ½ k+2 [(St+ Et+ Km)± V (St+ Et+ Km) 2 - 4 St· Et] (10 a. b.) 
We can drop the formula: 
v =-½ k+2 [(St+ Et+ Km)+ V (St+ Et+ Km)2 - 4 St· Et] (10a) 
because we know that v = 0 when St = 0 and Et = 0. 
Now, substitution of St= 0 and Et= 0 in equation 10a gives: 
V = ½k+2 [(0 + 0 +Km)+ V (0 + 0 + Km)2 - 4.0.0] (11) 
- v = k+ 2 • Km which is not true. Remains : 
V = ½ k+2 [(St+ Et+ Km) - V (St+ Et+ Km) 2 - 4 St· Et] (10b) 
We can replace the square root because: 
V V 4St·Et (St·Et·Km)2 -4St· Et= (St+ Et +Km) 1 - ~------
(St+ Et+ Km)2 
2St·Et 
R:;i (St+ Et+ Km) (1- (St + Et + Km)2) = 
2 St· Et 
St + Et + Km - St + Et + Km 
(This is only valid when (St + Et + Km)2 ► St • Et, which is true in our case.) 
Substitution of the square root in equation 10 b gives: 
or: 
k+2 ·St· Et 
V = St + Et + Km (l2) 
1 
V 
St+ Et+ Km 1 
k+2 • St · Et = St . 
Et+ Km 1 
k+2 • Et + k+2 • Et 
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k+ 2 1 1 Km 
-v-=Et+~+ Et·St (12') 
H 1 .. 1· d d 1 ere too, -1s m 1near epen ence on-S -. 
V t 
This implies that a plot analogous to the Lineweaver-Burk plot can be used 
when St ""'·Et.Some properties of the graph obtained when plotting in this way 
are shown in Fig. 3. (from now on the indexes t and m will be omitted when no 







1 E+K 1 -------------
K k 2 
(El 
Fig. 3. The Lineweaver-Burk plot under modified conditions. The relationship between+ and+ is 
shown for two different concentrations of enzyme (E and E') under conditions where S ► Eis not 
valid. 
When: 
1 1 1 
-S = 0 follows: -v = ---; - as in the classical formula - . 
k+ 2 • E 
When: 





Wiwn two ora.11ht1 of the ty1)e 1 = f ( 1 ) differ on.Iv a:;i to tlw amount of 
~ • 1 I' 8 • 
enzynw added. tlwy inttrcept in the point (a, b) in the third quadrant. 
l 
k:;-.-E; 
a= - E2-;.:k 
k+z . E2 
1 
J.·.2 • E: 
k+2 . E1 
---E; +-1t .. -
E1 -- E2 
K- 9 E·;--~ J{"~----.E2 -
So (a, b) is independent of E, and all lines representing 







f (s ) will 
Thu:;i variation of the enzyme eorwentration will result in a bundle of lines 
all passing through the point - - , 1 - -1- in the third quadrant - K .J,;., K . 
Further consideration of equation 12 shows that Sand E are located at symme-
trieal places; so S and E can be interchanged without changing the sense of the 
equation. 
This means that-~ is in 11 linear relationship to-~ when Sis constant, just 
as it is in a linear relationship to ~- when E is constant. This is an important 
difference from the rlassical formula, in which the relationship between v and E 
is linear. 
Plotting of · > ag1tinst ··~·· for different values of Swill also give a bundle of 
I. . t . h . 1 1 ) mes m erceptmg at t e pomt (- --Jc· - -I:
1
;-:J( . 
The fact that the coordinates of this point are equal in both the 1 - against 
1) 
1 l . 1 -E and the 1• agamst S plot gives us a method to compare the concentration 
of E and S on a molar basis. 
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In the following consideration the component of which the concentration is 
varied will by definition be called Substrate, and the constant component will be 
called Enzyme. This does not mean to say that it is the component Substrate 
which is converted into the product. 
When both enzyme and substrate are diluted at the same time, as is the case 
when they are present in the sample to be tested and not in the "reagent" we 




(n = constant) 
k+2 · n · S2 
v = --;( n-----:+~1 )-----=s:c--+-----:K= 
-~- = __!__ _ ( n + 1 + K 1 ) 
v S k+ 2 • n k+ 2 • n · S 
s 
V 
K __ 1 + n + 1 














Fig.4. The interaction of thrombin andfibrinogen. The final concentration of fibrin is given in mg%, 
the clotting time in seconds. 
Reaction medium: 0.1 ml fibrin to the concentration desired; 0.1 ml thrombin "Roche" 300 i.u. 
dissolved in Michaelis buffer pH 7 .4. 
An alternative explanation to these results is the following reaction mechanism: E + S :.± E. S; 
E. S + S :.:t E. S. S; E. S. S -> E + P-P. 
This would mean a first polymerization of fibrin on the enzyme rather than an independent poly-
merization of fibrin monomeres. 
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Wh K 1 1 K . en S ~ n + 1 then v R:J S2 . k+z . n 1s true. (20) 
K 1 n+ 1 1. 
When S «; n + 1 then v R:J k+z . n • S 1s true. (21) 
This shows that in this case we get a graph which in good approximation 
runs through the origin, and which will be straight in the neighbourhood of the 
origin, whereas at the right of the plot it will resemble a parabola. In practice 
this parabola can be recognized by plotting + against ; 2 , which will give a 
straight line. 
Possibly the data obtained from the action of partly purified thrombin on 
partly purified fibrinogen are an illustration of this case (Fig. 4). 
VI. The Effect of the Disappearance of Substrate during the Clotting - Time 
We assume that a test-system is chosen in such a way that only the factor to 
be tested is rate limiting, and that only the concentration of the factor to be 
tested is varied, while all the other factors are present in excess. Even in that 
case, estimation of the initial reaction-velocity from the clotting-time is possible 
only when the reaction rate does not change much during that time due to sub-
strate disappearance. 
Of course, product formation will result in substrate disappearance, and so 
the reaction-velocity will decrease during the time that elapses before clotting 
is observed. We now will consider whether this disappearance affects our 
estimation of the reaction-velocity. 
From the known formula of the reaction-velocity the relation between the 
amount of product formed at the time t (Pt) and the amount of substrate origi-
nally present (S0 ) can be calculated. 
k+ 2 • E · S 
K+E+S 
K E 
(1 + S + 8 ) · dS = - k+2 · E · dt 
St K E t 
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Now, since: 
So -St 
---=--- R:J 1, it follows that: 
So 
I St St - So 
n~ R:J So 
So: S - S0 + (K + E) ( S -;
0 
So)= - k+ 2 ,·E 
1 
or: Pt (1 + (K + E) · ~) = - k+2 • Et 
Pt (So+ K + E) = - k+2 ·Et· S0 
p _ k+2 • Et · So 





This will be true up to the moment that the approximative value of the 
I 'th . ( So - St di ogar1 m1c term So ) ffers less from the real value than the small 
amount that cannot be detected because it is obscured by the experimental 
error ( e). The difference between In _SS and So - 8t will be less than 
o So 
( So - St)2 b (So - St)2. . . ½ S ( ecause ½ S 1s the next term m the series development 
s 
ofln~)-
This implies that when ½ ( !: )2 is smaller than or equal to twice the stan-
dard deviation, the rest of the series development will have no measurable 
influence on the interpretation of the results. 
So, as long as t ( !: )2 remains smaller thane we may assume the inter-
relation between P and v to be rectilinear. 
This shows that at the usual experimental error of 2%, coagulation time is a 
fairly good measure for initial clotting reaction-velocity, when it can be assum-
ed that at the moment of clotting not more than v2 . -2- = 20 % of the initial 
100 
amount of the clotting-factor to be tested is consumed. In practice this condition 
will be fulfilled for factors I, II, VII, IX, X, XI, and XII. No details are known 
as to the behaviour of factors V and VIII in this respect. Generally spoken, dis-
appearance of substrate will not be a serious drawback to the application of a 
Lineweaver-Burk plot in the evaluation of clotting tests. 
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VII. The Clotting Time - Dilution Plot (t-D · Plot) 
Since £or clotting-factors the exact concentration expressed in molar units is 
always unknown, it is impossible to put the inverse of substrate concentration 
along the X-axis, as is to be done in the Lineweaver-Burk plot. 
When we estimate a clotting-time in a system which contains 100¾ of the 
clotting-factor to be tested, we can enter the value obtained (t100 , 1) in a recti-
linear coordinate system at a distance t 100 , 1 from the abscissa and at a distance 
D = 1 from the ordinate, 1 being an arbitrarily chosen unit of length. Now we 
estimate the clotting time in an analogous system, containing only 50¾ of the 
clotting-factor to be tested. This clotting-time (t100 , 2 ) we plot at a distance of 
2 l from the ordinate. In practice this set-up is realized when we add undiluted 
(dilution factor D = 1), twice diluted (D = 2), three times diluted (D = 3), etc. 
normal plasma to a reagent containing all necessary factors in excess except the 
factor to be tested, which it does not contain at all. The complications intro-
duced when the reagent does contain the factor to be tested will be discussed 
later. The resulting graph is directly comparable to the Lineweaver-Burk plot, 
because when a plasma is diluted n times and so contains 100/n ¾ of the factor, 
the corresponding clotting-time (inverse of reaction-velocity) is plotted at a 
distance n X 1 from the ordinate, so the distance from the ordinate will be 
inversely related to the substrate concentration. When we start the procedure 
r 
X /1 
- - I 
k , 1 
----- - - --- +-- - -
( E -E 1) X 
( E+ KI E1 
hK 
o-
Fig.5. The clotting time - dilution plot. The relationship between t and Dis shown for two different 
concentrations of substrate (x and x') and for two different concentrations of enzyme (E and E'). 
Kinetic Aspects of the Interaction of Blood Clotting Enzymes 167 
with plasmas containing less than 100% of the clotting-factor, we will get a line 
that runs steeper than the line obtained with normal plasma. It can be easily 
seen that the steepness of two lines reflects their relative concentrations; more 
exactly (Fig. 5), that the direction coefficient of the lines obtained is inversely 
related to the concentration of the clotting-factor in the starting plasma. The 
lines obtained with different starting plasmas will, however, all intercept at the 
same point on the ordinate, because this point indicates the clotting-time that 
would be obtained when an infinite concentration of substrate is added (a dilu-
tion factor of zero) and of course this minimal clotting-time (tmin) must be 
equal, no matter from what series the value has been extrapolated. It must be 
observed that two lines which differ because of the fact that the original plasmas 
contained different amounts of substrate would coincide in a real Lineweaver-
Burk plot, and are different only because of the fact that the scale on the abs-
cissa has a unit of length which is the inverse of the substrate concentration 
in the undiluted plasma. 
So ~- is not plotted against ½ as m the Lineweaver-Burk plot but 
t ( ~ -1-) is plotted against the dilution (D). 
V 
The substrate concentration in a given sample will be equal to the substrate 
concentration in the original plasma devided by the dilution factor. 
When the amount of clotting-factors present in a plasma is expressed as a 
fraction (x) of the amount present in normal plasma (so when the plasma 
contains 27% of a given factor, x = -22_) then the substrate concentration in a 
100 
given sample will be: 
X S = --- (29) 
D 
So our basic formula will change from: 
k+ 2 1 1 K v- = E + S- + -E-:--s-
into: 
1 K D 
t . h = --- + ( 1 + -) . ---
E E X 
where: t clotting-time 




a reaction constant 
( 12') 
(30) 
x - the amount of clotting-factors in the original plasma, expressed as 
a fraction from a standard amount 
D - dilution factor 
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[In practice we see that, for instance, the reference curve of Owren's thrombo-
test becomes a straight line when plotted in this way (ref. 10, 11 )]. 
Some of the properties of the graph thus obtained are: 
a) Intercept with the ordinate: (D = 0) 
t • h = ~ + (1 + ! ) · ~ 
1 
t= E·h 
b) Intercept with the abscissa: (t = 0) 
1 K D 
o = E + (1 + y). x 
X 
D = - (E + K) 
(31) 
(32) 
c) Two lines obtained in experiments in which the concentration of x in the 
original plasma differs, intercept at the point 
1 
(0,E) 
d) Two lines in experiments in which E differs, intercept at the point 
X 1 
-y,- h•K 
Proof: when the point of interception is ( a, b) then: 
K 1 1 
h•b=a(1+-)•-+-
E1 X E1 
K 1 1 
h•b=a(1+-)·-+-
E2 X E2 
1 1 
~-Ei X 
K 1 K 1=-7 
( 1 - E 2 ) • x - ( 1 - Ei) . x 
a= 
h-b=-1-+_1 ___ 1_= __ 1_ 
K E2 E 1 K 
This is an intercept in the third quadrant. 
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t · h = ~ + (1 + ! ) . ~ 
1 1 E + K D' 
y=7r+( E )·x 
E = E' + (E · E' + K. E'). ~ 
X 




D' = (E - E') . X 
E' · (E + K) 
When D' remains constant the relationship between E' and x will be: 
_1_ = _1 + (E + K) . D' . _1 
E' E E X 
and the relationship between E and x will be: 
E = _ E' (K · D' + x) 
(E'. D' - x) 
When: E' • D' ~ x, this can be simplified into: 
E = - E' ( D' . K + 1) 
X 
so: 
E D'-K -w= -( X + 1) 
E 1 









The developments sub e) are of importance because they contain an alter-
native explanation for the graphical picture obtained by addition of inhibitors. 
7 
I 
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VIII. Addition of Substrate which is not Free of Enzyme 
Because it is rather difficult to get different clotting-factors separated and 
in a pure state, the situation that the enzyme of a reaction is added along with 
the substrate will be frequently encountered. In that case the amount of enzyme 
(En) in dilution will be dependent upon the dilution (D). 
So: 
and: 
1 K 1 




D D E 1 
t-h =E+ E· (K + n) ·x·D 
K 1 1 1 1 
=D2 (-E·x +n· (E +x)) 
for D = 0 is t = 0; so the graph passes through the origin. 
The graph is approximately straight when: 
K 1 1 1 
D•--•- ~-+- or: E X E X 
D • K ~ x + E; this is usually true because K is very small. 
In that case the formula ( 41) is written as follows: 
1 1 
t · h ~ D (E + x) 
The graph is in approximation a parabola when: 
K 1 1 1 
D---·- ►-+-E X E X 
D-K ► x+E 










When E is present in both the original plasma and the reagent, it will vary 
with the dilution to a lesser extent. 
En= E + -£ (43 
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(Ex = the amount of enzyme in the original plasma; E = the amount of enzyme 
in the reagent.) 
By substitution of (43) into (30) it follows that: 
t-h= D D-K 1 
D · E + Ex + ( l + -D · Ef+ Ex ) . x . D 
D 2 (E + K) + D (x + Ex) 
D · E + Ex 
t . h = D . _1. D (E + K) + Ex + X 





When specific conditions are fulfilled this formula can be used in a simplified 
form. 
D-K ;,,- X 
} D K -+t•h=-(--+1) ( 46) 
D-E ► Ex X E 
D-K ;,,- X 
} D D2 K -+t•h=---+-- (47) 
D -E ~ Ex x xEx 
D-K ~ X 
} D 1 -+t•h=-+- ( 48) 
D-E ► Ex X E 
D-K ~ X 
} D D -+t•h=-+- ( 49) 
D- E ~ Ex X Ex 
X. The Buffer Value 
The general procedure for the estimation of a clotting-factor is addition of 
that clotting-factor to a mixture containing all factors but the factor to be 
tested in excess. 
In practice it is seen that the mixture itself, without addition of the clotting-
factor in which it is deficient, will clot in a certain time (buffer value) after recal-
cification. This can be due to either one or a combination of two phenomena. 
1) The clotting-factor proceeds independently of the factor to be tested, via a 
pathway for which this factor is not a missing link. In that case, the clotting-
velocity (vt) after addition of an unknown amount of the factor to be tested and 
recalcification will be the sum of the separate velocities along the two indepen-
dent pathways. 
When Vt is the velocity due to the clotting-factor added in variable amounts, 
vb is the velocity due to the parallel pathway, tt is the clotting-time found when 
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the variable factor is added and tb is the clotting-time when the factor to be 
tested is not added, it follows that, 









1 _ tt · tb . h (50) 
Vf tb - tt 
The values obtained from factor VIII or factor IX estimation according to 
Biggs (ref. 6) seem to be an illustration of this case (Fig. 6). 
2. A second possible cause of the "buffer value" is that the "reagent" 
contains a certain amount of substrate. In that case the buffer value will depend 
upon the amount of clotting-factor present in the reagent (Sb)-
tb. h = K + E + Sb ; Sb= K + E (12) (51) 
E · Sb E · tb · h - 1 
When substrate is added in the amount Sx it follows that: 
tt . h = K + E + (Sb + Sx) _ Sb + Sx = K + E 
E (Sb + Sx) E · tt · h - 1 (52) 
From (51) and (52) it follows that: 
1 (tb · h · E - 1) (tt · h · E - 1) 
S~ - (E + K) (E · h) (tb - tt) (53) 
So there is no longer a linear relationship between Slx and tt. 
This formulas can be rearranged as follows: 
tb - tt 1 1 
Sx = ~. tt - Sb · E · h (54) 
So (tb - tt): Sx varies linearly with tt. 
It is now possible to plot tt against (tb - tt): Sx in a linear graph and deduce 
Sb from the slope of that graph (ref.12). After correction for the value of Sb, 
which is now known, it will be possible to make a t-D graph to check the vali-
dity of the method. This is illustrated in Fig. VII. It can be imagined that the 
values obtained in the system shown in Figs. VI and VII can very well simulate 
a straight line when plotted directly on a double logarithmic scale. Although it 
is not claimed that this is the sole explanation of the frequently encountered 






























Fig. 6. Time - dilution plot of a factor IX estimation. For reaction procedure see: ref. 6. The data 
obtained in the test ( ®) do not fit in a straight line unless they have been corrected for the buffer 
value ( e ). In the latter case the steepness of the line obtained, again reflects the amount of 
factor IX present in the original plasma. Here normal plasma (---) and plasma from a known 
carrier of haemophilia B (- - - -) are compared. The carrier plasma exhibiting 54% activity. It can 
directly be seen that the diminished activity is not due to an inhibitor, as tmin is equal in both cases. 
phenomenon of a straight line in a double logarithmic scale, it offers at least one 
explanation. 
Another possible explanation is that tt ,reflects tlie integrated form of the 
velocity-concentration curve, as could be the ease when a series of reactions is 
coupled. Further theoretical and practical work on this point is in progress in 
our laboratory. 
Summary 
Application of the methods of enzyme-kinetic analysis to the results of 
clotting tests is feasible and can yield useful results. However, the standard 
methods of enzyme kinetics are not applicable without modifications imposed 
by the peculiarities of the blood-clotting enzyme system. The influence of the 
following complicating circumstances is calculated: 
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Fig. 7. The Lineweaver-Burk plot of a one stage factor 11 assay. The left graph shows the failure to 
obtain a straight line with uncorrected values, the middle graph shows the graph from which the 
correction value is obtained. The right graph shows the Lineweaver-Burk plot of the corrected 
values. The points are obtained as the mean of 60 to 300 estimations. The vertical lines in the center 
dots represent 4 times the standard deviation. In the outer dots, 4 times the standard deviation 
falls within the dot. 
1. Substrate is not present in excess. 
2. Only relative measures exist for concentrations of substrate or enzymes. 
3. Enzymes and substrates are often added together. 
4. Reagents are not pure. 
5. Clotting-time is our only measure for clotting-velocity. 
Formulas are deduced, which makes it possible to recognize the effect of 
these complications. 
Resume 
II est possible d'appliquer les methodes de l'analyse cinetique enzymatique 
aux resultats obtenus avec des tests de coagulation et d'en tirer une information 
valable. Neanmoins les methodes standard de la cinetique enzymatique ne sont 
pas applicables sans les modifications imposees par les particularites du systeme 
enzymatique de la coagulation sanguine. On a pris en consideration l'inf:l.uence 
des conditions suivantes qui compliquent le probleme. 
1. Le substrat n'est pas present·en exces. 
2. Il existe seulement des mesures relatives de la concentration des sub-
strats ou enzymes. 
3. Les enzymes et substrats sont souvent ajoutes ensemble. 
4. Les reactifs ne sont pas purs. 
5. Le temps de coagulation est notre seule mesure de la vitesse de coagula-
tion. 
De cette etude on deduit des formules qui rendent possible l'evaluation de 
l'effet de ces complications. 
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Zusammenfassung 
Die Anwendung der Methoden der enzymkinetischen Analyse auf die Ergeb-
nisse der Blutgerinnungsteste ist moglich und kann zu niitzlichen Ergebnissen 
fiihren. Die Standardmethoden der Enzymkinetik konnen jedoch nicht ohne 
Modifikationen angewendet werden, die durch die Eigenheiten des Blut-
gerinnungsfermentsystems verursacht werden. Der EinfluB der folgenden kom-
plizierenden Umstande wird berechnet: 1. Das Substrat liegt nicht im Uber-
schuB vor, 2. es gibt nur relative Messungen der Konzentrationen von Sub-
strat oder Enzym, 3. Enzyme und Substrate werden haufig gleichzeitig zuge-
setzt, 4. die Reagentieil sind nicht rein, 5. die Gerinnungszeit ist die einzige MaB-
zahl fiir die Bestimmung der Gerinnungsgeschwindigkeit. Es werden Formeln 
abgeleitet, welche es moglich machen, die Einfliisse dieser Komplikationen zu 
erkennen. 
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